2291.HK
2291.HK
CNE1000057M5
SCIENTECH
Loading chart...

Company Profile

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., an investment holding company, engages in the manufacture and sale of interventional treatment series occluders and heart valve medical devices. It operates through Occluder Business and Heart Valve Business segments. The company also researches, develops, manufacture, and sale interventional treatment series occluders for defective congenital heart disease; and manufacture and sale heart valve medical devices. Its products include atrial septal defect, ventricular septal defect, patent ductus arteriosus, patent foramen ovale, left atrial appendage, and aortic and peripheral occluders, as well as aortic and mitral valve occluder products; atrial septal puncture and procedural accessories; interatrial shunt device; mechanical circulatory support products; and hypertensive device treatment products. In addition, it is involved in manufacturing industry; technology development; and trading activities. The company serves its products through distributors and direct sales. LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. operates as a subsidiary of Lepu Medical Technology (Beijing) Co., Ltd.

Related stocks

2172.HK
2172.HK • China
MICROPORT NEURO
8.06 HKD
583.6M USD 1Y -35.5%
1789.HK
1789.HK • China
AK MEDICAL
4.67 HKD
628.46M USD 1Y -16%
2697.HK
2697.HK • China
TH MEDICAL-B
183 HKD
1.2B USD
300298.SZ
300298.SZ • China
CHANGSHA SINOCARE
16.68 CNY
1.39B USD 1Y -16.4%
688575.SS
688575.SS • China
SHENZHEN YHLO BIOTECH CO LTD
10.46 CNY
894.36M USD 1Y -28.1%
1302.HK
1302.HK • China
LIFETECH SCI
1.35 HKD
757.09M USD 1Y -36.9%
600055.SS
600055.SS • China
BEIJING WANDONG MEDICAL TECHNOL
10.48 CNY
1.1B USD 1Y -41.3%
2675.HK
2675.HK • China
EDGE MEDICAL-B
33 HKD
1.64B USD

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
58.1% p.a.
Max Drawdown (5Y)
-75.2%
Sharpe Ratio (5Y)
-0.35
Beta Factor
-0.14
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (58.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -75.2% in the extended horizon.
ende